Drug

New tax will hit branded drugs and active ingredients while exempting generics for at least one yearSign up for the Breaking News US email to get newsletter alerts in your inboxDonald Trump is threatening 100% tariffs on pharmaceutical companies that have not struck deals to lower US drug prices.The new tariff will only apply to branded drugs and their active ingredients. Generic drugs, which make up more than 90% of medicines sold in the US, will be exempted from tariffs for at least one year. Orphan, veterinary and other specialty drugs are exempt if they are from trade deal countries or meet urgent public health needs. Continue reading...

‘Partnership’ on drug pricing also gives patients in Britain greater access to potentially life-extending treatments British drug exports to the United States will escape tariffs imposed by Donald Trump as part of a controversial UK-US medicines deal that critics fear will mean less money for the NHS.The deal will also give patients in Britain greater access to potentially life-extending drugs because the rules have been relaxed to allow the NHS to pay more for particular treatments. Continue reading...

• FDA announced on April 1, 2026, that new drug approvals last year reached near-record levels, surpassing five-, ten-, and multi-year averages. • This update highlights continued acceleration in innovative therapies reaching US patients, boosting treatment options for various diseases. • Strong approval momentum underscores FDA's commitment to expediting safe, effective drugs amid public health priorities like cancer and rare diseases.

US firm Eli Lilly, which is also pushing for end to rebate scheme, optimistic about talks with ministersThe US pharmaceutical group behind the Mounjaro weight-loss drug has said it will unpause its UK investments if ministers agree to regularly increase NHS drug prices and end a rebate scheme.Patrik Jonsson, the president of Eli Lilly’s international business, said the company was in talks with UK ministers and that he was optimistic about reaching an agreement this summer for Britain to pay more for its medicines. Continue reading...

• Major U.S. health insurers are limiting coverage of GLP-1 drugs like Ozempic and Wegovy to their original FDA-approved use for diabetes management, excluding weight loss treatments. • According to industry analyst Andy, this shift reverses prior expansions amid rising costs and supply shortages, affecting millions of patients seeking obesity care. • The policy change aims to control spending on these high-demand medications, which have seen off-label use surge, potentially pushing patients toward alternatives or out-of-pocket payments.

Matthew Uthoff and his wife, Amber Dena Snow, allegedly gave oxycodone-laced pasta dish to unknowing victimTwo people in Iowa were accused of giving a pregnant woman a lasagna laced with narcotics with the intention of causing a miscarriage, according to law enforcement.Matthew Uthoff, 35, and his wife, 36-year-old Amber Dena Snow, are accused of delivering a lasagna containing oxycodone to the pregnant individual. The couple faces several charges including delivery of a controlled substance and purposefully terminating a human pregnancy without the knowledge and voluntary consent of the pregnant individual. Continue reading...

• A joint U.S.-Ecuador military strike on March 6 targeting an alleged narco-terrorist training camp actually destroyed a dairy farm in the remote Ecuadorian village of San Martín in the Amazon jungle, according to a New York Times investigation. • Defense Secretary Pete Hegseth posted video of the strike online claiming the U.S. was "bombing Narco Terrorists on land," but local residents reported Ecuadorian soldiers had arrived three days earlier by helicopter, interrogated and beat farmworkers, and set fire to structures before the bombing occurred. • The Alliance for Human Rights, an Ecuadorian coalition, filed a 13-page complaint with Ecuadorian authorities and the United Nations over the incident, raising serious questions about civilian casualties and military conduct in the operation.